Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Arog Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Arog Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2941251Mar 7, 2018Crenolanib For Treating Flt3 Mutated Proliferative Disorders1